Radiopharm approved to start Lu-RAD202 safety trials, door open for in-human studies
Radiopharm Theranostics Ltd (ASX:RAD) has received ethics approval to begin its Phase…
Radiopharm Theranostics Limited (ASX:RAD)
About Radiopharm Theranostics Limited
Key Information
RAD In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 08.51am 20/12/2024 | Price Sensitive PS RAD 202 receives approval to start Phase 1 therapeutic trial | 88.43KB | 921 |
| 19/12/2024 | Notice Under Section 708A | 145.27KB | 340 |
| 19/12/2024 | Application for quotation of securities - RAD | 17.64KB | 421 |
| 19/12/2024 | Price Sensitive PS Response to ASX Aware Letter | 812.59KB | 331 |
| 18/12/2024 | Notification of cessation of securities - RAD | 14.32KB | 211 |
| 18/12/2024 | Change of Director's Interest Notices x7 | 745.66KB | 219 |
| 18/12/2024 | Notification regarding unquoted securities - RAD | 17.84KB | 169 |
| 18/12/2024 | Application for quotation of securities - RAD | 16.56KB | 428 |